Dr Reddy's Laboratories Ltd (RDY)
71.85
-0.82
(-1.13%)
USD |
NYSE |
Jun 14, 16:00
71.89
+0.04
(+0.06%)
Pre-Market: 20:00
Dr Reddy's Laboratories Research and Development Expense (Quarterly): 82.81M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 82.81M |
| December 31, 2023 | 66.84M |
| September 30, 2023 | 65.88M |
| June 30, 2023 | 60.67M |
| March 31, 2023 | 65.33M |
| December 31, 2022 | 58.71M |
| September 30, 2022 | 61.03M |
| June 30, 2022 | 56.06M |
| March 31, 2022 | 57.52M |
| December 31, 2021 | 55.48M |
| September 30, 2021 | 60.23M |
| June 30, 2021 | 61.48M |
| March 31, 2021 | 56.14M |
| December 31, 2020 | 55.54M |
| September 30, 2020 | 58.48M |
| June 30, 2020 | 52.24M |
| March 31, 2020 | 57.70M |
| December 31, 2019 | 55.38M |
| September 30, 2019 | 51.92M |
| June 30, 2019 | 51.80M |
| March 31, 2019 | 51.93M |
| December 31, 2018 | 50.84M |
| September 30, 2018 | 58.73M |
| June 30, 2018 | 62.01M |
| March 31, 2018 | 67.57M |
| Date | Value |
|---|---|
| December 31, 2017 | 72.14M |
| September 30, 2017 | 64.94M |
| June 30, 2017 | 78.69M |
| March 31, 2017 | 68.36M |
| December 31, 2016 | 73.53M |
| September 30, 2016 | 77.89M |
| June 30, 2016 | 71.77M |
| March 31, 2016 | 72.27M |
| December 31, 2015 | 62.12M |
| September 30, 2015 | 68.90M |
| June 30, 2015 | 69.19M |
| March 31, 2015 | 82.65M |
| December 31, 2014 | 69.67M |
| September 30, 2014 | 67.85M |
| June 30, 2014 | 64.78M |
| March 31, 2014 | 64.49M |
| December 31, 2013 | 48.03M |
| September 30, 2013 | 48.45M |
| June 30, 2013 | 43.64M |
| March 31, 2013 | 42.94M |
| December 31, 2012 | 37.38M |
| September 30, 2012 | 31.87M |
| June 30, 2012 | 29.01M |
| March 31, 2012 | 23.78M |
| December 31, 2011 | 29.84M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
51.80M
Minimum
Jun 2019
82.81M
Maximum
Mar 2024
59.56M
Average
58.09M
Median
Research and Development Expense (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| ASLAN Pharmaceuticals Ltd | 5.895M |
| Zai Lab Ltd | 54.64M |
| ICICI Bank Ltd | -- |
| SS Innovations International Inc | 0.073M |